U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
HYALURONIC ACID (NON-ANIMAL STABILIZED)
B7SG5YV2SI
Possibly Marketed Outside US
First approved in 2011
General
Record Details
Names
7
Classification
7
Identifiers
6
Display Structure
Relationships
1
Modifications
1
Characteristic Attributes
1
HYALURONIC ACID (NON-ANIMAL STABILIZED)
B7SG5YV2SI
Possibly Marketed Outside US
First approved in 2011
General
Approval Year
2011
587
Record Details
Substance Class
Polymer
Record UNII
B7SG5YV2SI
Record Status
Validated (UNII)
Record Version
12
11
10
9
8
7
6
5
4
3
2
1
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
HYALURONIC ACID (NON-ANIMAL STABILIZED)
Official Name
English
DUROLANE
Preferred Name
English
PERLANE
Brand Name
English
HYALURONAN (NON ANIMAL)
Common Name
English
NASHA
Common Name
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Classification
7
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Other cicatrizants
ATC
DERMATOLOGICALS
PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
CICATRIZANTS
Other cicatrizants
hyaluronic acid
WHO-ATC
D03AX05
Designated
ORPHAN DRUG
Designated
Treatment of emphysema in patients due to alpha-1 antitrypsin deficiency
FDA ORPHAN DRUG
153501
Other drugs for disorders of the musculo-skeletal system
ATC
MUSCULO-SKELETAL SYSTEM
OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
Other drugs for disorders of the musculo-skeletal system
hyaluronic acid
WHO-ATC
M09AX01
Viscoelastic substances
ATC
SENSORY ORGANS
OPHTHALMOLOGICALS
SURGICAL AIDS
Viscoelastic substances
hyaluronic acid
WHO-ATC
S01KA01
Viscoelastic substances
ATC
SENSORY ORGANS
OPHTHALMOLOGICALS
SURGICAL AIDS
Viscoelastic substances
hyaluronic acid, combinations
WHO-ATC
S01KA51
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
ECHA (EC/EINECS)
232-678-0
PRIMARY
WIKIPEDIA
HYALURONAN
PRIMARY
DAILYMED
B7SG5YV2SI
PRIMARY
FDA UNII
B7SG5YV2SI
PRIMARY
CAS
9004-61-9
GENERIC (FAMILY)
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Display Structure
Export Data
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
YSE9PPT4TH
HYALURONATE SODIUM
SALT/SOLVATE -> PARENT
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Modifications
1
Agent Modifications
Show
5
20
100
All
entries
Modification Process
Modification Role
Modification Type
Amount
Fragment Name
Fragment ID
Modification Process
Modification Role
Modification Type
Amount
Fragment Name
Fragment ID
CROSSLINKING
CROSSLINKING
WEIGHT PERCENT 1 % (average)
1,4-BUTANEDIOL DIGLYCIDYL ETHER
E9MU425FIB
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
1
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
MOL_WEIGHT:WEIGHT AVERAGE
CHEMICAL
[>1000000] DALTONS (average)
Showing 1 to 1 of 1 entries
Previous
1
Next
